SGO 2022 Conference Coverage on VuMedi

 

SGO 2022 Conference Coverage on VuMedi
Q

SGO 2022 Effectiveness & Safety of Neoadjuvant Niraparib in Advanced Ovarian Cancer With HRD: A Prospective, Multicenter Phase 2 Single-Arm Study (NANT)

By SGO 2022 Conference Coverage on VuMedi FEATURING Qinglei Gao
By SGO 2022 Conference Coverage on VuMedi FEATURING Qinglei Gao
30 views
May 13, 2022
Comments 0
Login to view comments. Click here to Login
Videos
06:44

SGO 2022 Effectiveness & Safety of Neoadjuvant Niraparib in Advanced…

SGO 2022 Conference Coverage on VuMedi

Q. Gao

30 views
10:52

SGO 2022 on Health Care Services Burden in Ovarian Cancer Patients R…

SGO 2022 Conference Coverage on VuMedi

D. Chase

188 views
07:31

SGO 2022 on Pembrolizumab for Persistent, Recurrent, or Metastatic C…

SGO 2022 Conference Coverage on VuMedi

D. Barrington

239 views
05:21

SGO 2022 Phase II Trial of Maintenance Niraparib in Stage III/IV or …

SGO 2022 Conference Coverage on VuMedi

M. Frimer

203 views
08:08

SGO 2022 Final OS Results From SOLO3: Phase III Trial Assessing Olap…

SGO 2022 Conference Coverage on VuMedi

R. Penson

337 views
06:03

SGO 2022 on a Phase 2 OVARIO Study of Niraparib + Bevacizumab in Adv…

SGO 2022 Conference Coverage on VuMedi

M. Hardesty

289 views
13:30

SGO 2022 on a Randomized Phase 3 Trial of IP vs. IV Carboplatin With…

SGO 2022 Conference Coverage on VuMedi

K. Fujiwara

273 views
11:28

SGO 2022 on Clinical Outcomes of Ovarian Cancer Patients Treated Wit…

SGO 2022 Conference Coverage on VuMedi

I. Winer

246 views
11:28

SGO 2022: Recognition and Management of Side Effects Associated With…

SGO 2022 Conference Coverage on VuMedi

M. Raza Mirza

133 views
10:41

SGO 2022: Development of an Interactive Precision Medicine Dashboard…

SGO 2022 Conference Coverage on VuMedi

A. Haggerty

58 views
07:22

SGO 2022 on Shared Decision Making in Frontline Maintenance Therapy …

SGO 2022 Conference Coverage on VuMedi

A. Haggerty

214 views
09:08

SGO 2022 on Maintenance Therapy in Advanced Ovarian Cancer: Results …

SGO 2022 Conference Coverage on VuMedi

D. Chase

279 views
07:24

SGO 2022 Update on Maintenance Olaparib Rechallenge in Patients With…

SGO 2022 Conference Coverage on VuMedi

E. Pujade-Lauraine

74 views